These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 38412322
1. Exploration of the utility of different doses of Qingfei Dayuan granules: a multicenter, randomized, double-blind, placebo-controlled trial. Zhu X, Li W, Yang Y, Li H, Yang M, Zhang J, Li X, Yan G, Wu X, Zhao W, Cui M, Yang X, Hu X, Huang J, Ba Y. Aging (Albany NY); 2024 Feb 26; 16(5):4503-4517. PubMed ID: 38412322 [Abstract] [Full Text] [Related]
2. Effectiveness and safety of Qingfei Dayuan granules for treating influenza and upper respiratory tract infections manifested by the pulmonary heat-toxin syndrome: A multicenter, randomized, double-blind, placebo-controlled trial. Li W, Xie L, Zhu X, Yang Y, Wang L, Yang M, Li H, Li X, Yan G, Wu X, Zhao W, Zhang J, Yang G, Guo Y, Li C, Wang R, Shi L, Xiong Z, Xu P, Kong W, Cui M, Yang X, Ba Y. Front Pharmacol; 2023 Feb 26; 14():1133560. PubMed ID: 37007028 [Abstract] [Full Text] [Related]
5. Efficacy and safety of Qingfei Huatan formula in the treatment of acute exacerbation of chronic obstructive pulmonary disease: A multi-centre, randomised, double-blind, placebo-controlled trial. Zhu HZ, Li CY, Liu LJ, Tong JB, Lan ZH, Tian SG, Li Q, Tong XL, Wu JF, Zhu ZG, Li SY, Li JS. J Integr Med; 2024 Sep 26; 22(5):561-569. PubMed ID: 39060126 [Abstract] [Full Text] [Related]
9. Anti-inflammatory, anti-tussive effects and toxicity evaluation of Qingfei Dayuan granules. Huanbo C, Hui HU, Daihua S, Guangzhong W. J Tradit Chin Med; 2023 Oct 26; 43(6):1110-1117. PubMed ID: 37946473 [Abstract] [Full Text] [Related]
10. [Efficacy and safety of Kangbingdu granules in the treatment of influenza: a randomized, double-blind, double-dummy, positive-drug parallel control multicenter clinical trial]. Nong Y, Lin JT, Sun XW, Wang J, Ma X, Liu XP, Wang HQ, Zha RT, Shen DP, Jiang SJ, Luo SK, Zhao Q, Meng L, Wang WP, Fang J, Han LM, Lu GB, Zhang W, Li GF, Wang H, Zhao ZY, Zhou W, Wei BL, Yuan YD, Peng LP, Lu XL, Pang GF, Li FH, Li L, Zhen H. Zhonghua Yi Xue Za Zhi; 2021 Jan 19; 101(3):205-211. PubMed ID: 33370867 [Abstract] [Full Text] [Related]
11. [Systematic review and Meta-analysis of efficacy and safety of Shufeng Jiedu Capsules in treatment of influenza]. Zhou F, Zhao GZ, Li B, Xu XL, Shi YF, Mao YY, Tian JH, Liu QQ. Zhongguo Zhong Yao Za Zhi; 2023 Nov 19; 48(22):6216-6224. PubMed ID: 38114228 [Abstract] [Full Text] [Related]
12. Efficacy and safety of herbal medicine (Binafuxi granules) for the common cold with fever: A multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Liu X, Min J, She B, Chen Y, Li J, Huang L, Chen J, Luo A, Yang M, Li T, Wu Y, Chen D, Zhong H, Liu W, Mao B, Jiang H. Integr Med Res; 2023 Sep 19; 12(3):100956. PubMed ID: 37359288 [Abstract] [Full Text] [Related]
13. Clinical, double-blind, placebo-controlled study investigating the combination of acetylsalicylic acid and pseudoephedrine for the symptomatic treatment of nasal congestion associated with common cold. Loose I, Winkel M. Arzneimittelforschung; 2004 Sep 19; 54(9):513-21. PubMed ID: 15500197 [Abstract] [Full Text] [Related]
14. [Ergoferon liquid dosage form--efficacious and safe treatment for childhood acute respiratory infections. Interim outcomes of a multi-center, randomized, double-blind, placebo-controlled clinical trial]. Geppe NA, Kondiurina EG, Galustian AN, Pak TE, Bal'tserovich NB, Zhiglinskaia OV, Kamaev AV, Lazareva SG, Laléko SL, Mel'nikova IM, Perminova OA, Sabitov AU. Antibiot Khimioter; 2014 Sep 19; 59(5-6):6-14. PubMed ID: 25552038 [Abstract] [Full Text] [Related]
17. Efficacy and safety of Chou-Ling-Dan granules in the treatment of seasonal influenza via combining Western and traditional Chinese medicine: protocol for a multicentre, randomised controlled clinical trial. He J, Li Z, Huang W, Guan W, Ma H, Yang ZF, Wang X. BMJ Open; 2019 Apr 02; 9(4):e024800. PubMed ID: 30944133 [Abstract] [Full Text] [Related]
18. Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial. Lu CL, Yang LQ, Jin XY, Friedemann T, Li YF, Liu XH, Chen XY, Zou XY, Zhang BR, Wang FX, Lin YL, Tang YM, Cao ML, Jiang YL, Gao YF, Liu K, Tao ZG, Robinson N, Schröder S, Liu JP, Lu HZ. Front Pharmacol; 2024 Apr 02; 15():1383831. PubMed ID: 38863976 [Abstract] [Full Text] [Related]
19. Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study. Bachert C, Chuchalin AG, Eisebitt R, Netayzhenko VZ, Voelker M. Clin Ther; 2005 Jul 02; 27(7):993-1003. PubMed ID: 16154478 [Abstract] [Full Text] [Related]
20. Efficacy and safety of Lian-Ju-Gan-Mao capsules for treating the common cold with wind-heat syndrome: study protocol for a randomized controlled trial. Wang S, Jiang H, Yu Q, She B, Mao B. Trials; 2017 Jan 05; 18(1):2. PubMed ID: 28057058 [Abstract] [Full Text] [Related] Page: [Next] [New Search]